Enliven Therapeutics, Inc. (ELVN) Earnings
NASDAQ·Healthcare·Biotechnology
$46.17
-4.18%
Mkt Cap $3.49B
EPS — Estimate vs Actual
Mkt Cap
$3.49B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.64
NASDAQ·Healthcare·Biotechnology
$46.17
-4.18%
Mkt Cap $3.49B
Mkt Cap
$3.49B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.64